GENERAL ORTHOPAEDICS
AAOS2018: Similar analgesia with 30mL 0.6% vs. 0.75% ropivacaine in femoral-sciatic nerve block
339 patients scheduled for lower extremity surgery were randomized to have an ultrasound-guided, combined femoral and sciatic nerve block completed with either 40mL 0.5% ropivacaine, 30mL 0.6% ropivacaine, or 30mL 0.75% ropivacaine. Patients were assessed for time to complete anesthetic onset, intraoperative and postoperative pain score, patient satisfaction, and incidence of adverse events. In comparing different volumes, pain scores were significantly higher among patients treated with 40mL 0.5% ropivacaine compared to 30mL 0.75% ropivacaine at 6 and 12 hours postoperatively. In comparing concentration, no significant differences in pain or patient satisfaction were observed between 30mL 0.6% ropivacaine and 30mL 0.75% ropivacaine.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
